More on INNPF

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Innocan Pharma Corp (OP:INNPF)
Delayed: 2.19 +0.59 (36.88%)
Prev. Close $1.60  
Open$2.19 
52 Wk High$ 
52 Wk Low$ 
Day High$2.19 
Day Low$2.19 
P/E N/A  
EPS$ 
Volume106 

Friends, Peers and Foes (?): INNO IP4 (more...)

Mar 31, 2026 03:00 AM Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
Feb 9, 2026 09:08 AM Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
Jan 27, 2026 04:00 PM Innocan Pharma plans NYSE American listing around January 30
Jan 27, 2026 04:00 PM Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Jan 2, 2026 07:00 AM Innocan Pharma anticipates NYSE American listing around January 7
Jan 2, 2026 07:00 AM Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Sep 5, 2025 09:15 AM Form FWP INNOCAN PHARMA Corp Filed by: INNOCAN PHARMA Corp
Sep 5, 2025 09:01 AM Form F-1/A INNOCAN PHARMA Corp
Aug 4, 2025 03:20 PM Form F-1/A INNOCAN PHARMA Corp
Jul 23, 2025 05:14 PM Form F-1 INNOCAN PHARMA Corp
View All Articles

Entities mentioned with INNPF

View All Entities